Zachodniopomorskie Centrum Onkologii

What Zachodniopomorskie Centrum Onkologii does

Zachodniopomorskie Centrum Onkologii (ZCO) is a public regional oncology hospital headquartered in Szczecin, Poland, serving as the primary cancer diagnosis and treatment center for the entire West Pomeranian Voivodeship (Województwo Zachodniopomorskie). Founded in 2010 and operating under the governance of Director Adrian Sikorski, ZCO delivers comprehensive multidisciplinary cancer care across surgical oncology, clinical radiotherapy, systemic therapy (chemotherapy, hormone therapy, immunotherapy), diagnostic imaging, pathomorphology, psycho-oncology, oncofertility counseling, and rehabilitation. The hospital is one of 16 provincial cancer registry centers in Poland (operating the Wojewódzkie Biuro Rejestracji Nowotworów) and coordinates the National Cancer Network (Krajowa Sieć Onkologiczna) for the voivodeship.

ZCO's technology and service platform spans modern radiotherapy equipment for the region, an electronic patient registration portal (e-Rejestracja), the iWound telemedicine application for post-operative wound monitoring (co-developed with the Medical University of Poznań), an online Exercise Atlas for onco-rehabilitation, and a planned Nuclear Medicine Center (opening January 2027, ~50 million PLN investment) equipped with Biograph Vision.X PET/CT and Symbia pro.specta X3 SPECT/CT scanners for scintigraphy and radiopharmaceutical therapy. The hospital is constructing additional infrastructure under the 'SOLO III' strategic expansion project and participates in multiple EU-funded programs (RPO WZ 2014-2020, REACT-EU) for equipment and e-services.

The business model is publicly funded through Poland's National Health Fund (NFZ), with insured citizens accessing services free of charge at point of care; supplementary revenue comes from selected fee-based services (świadczenia płatne, 'Dobry posiłek' program), EU/regional infrastructure grants, and Marshal's Office project funding. Patient acquisition is driven by NFZ/POZ referrals, electronic self-registration, call center scheduling, and community outreach including free screening campaigns (mammography, dermoscopy), school and workplace prevention workshops, and media-driven awareness campaigns such as 'Rak piersi nie ma barw' (Breast Cancer Has No Colors) and the national 'Cała Polska sprawdza znamiona' melanoma screening initiative.

Name

Zachodniopomorskie Centrum Onkologii

Legal name

Zachodniopomorskie Centrum Onkologii

Website

https://onkologia.szczecin.pl

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

251–500 employees

Short description

Zachodniopomorskie Centrum Onkologii is a public regional oncology hospital in Szczecin, Poland, providing comprehensive cancer diagnosis, treatment, and rehabilitation services to the West Pomeranian Voivodeship population under National Health Fund (NFZ) reimbursement.

Ownership category

akta.pro rank

Product category

Oncology Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (62231)

SIC

Services-Hospitals (8060)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Medical Oncology (HLAKAFAB), Oncology Telemedicine Platforms (HLALAGAH)

Keywords

• Oncology hospital services
• Cancer treatment services
• Radiotherapy chemotherapy
• Cancer screening programs
• Oncological rehabilitation

Headquarters

HQ city

Szczecin

HQ country

Poland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Publicly Funded Healthcare Services (NFZ): ZCO is a public oncology hospital whose core services are funded by Poland's National Health Fund (Narodowy Fundusz Zdrowia, NFZ). All insured citizens have access to diagnostic and treatment services under the public healthcare system.
2. Paid Medical Services (Świadczenia Płatne): The hospital offers certain paid medical services outside the NFZ benefit package, including services under the 'Dobry posiłek' (Good Meal) program and other fee-based treatments.
3. EU and Regional Project Funding: ZCO receives EU and government co-funding for infrastructure projects (nuclear medicine center, equipment upgrades, e-services) through Regionalny Program Operacyjny Województwa Zachodniopomorskiego 2014-2020 and other programs.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels7 records

Core offering

Zachodniopomorskie Centrum Onkologii is a public regional oncology hospital that diagnoses and treats cancer patients through surgical oncology, clinical radiotherapy, systemic therapy (chemotherapy, hormone therapy, immunotherapy), psycho-oncology, oncological physiotherapy, and palliative/supportive care. It also runs population-level cancer screening and prevention programs (mammography, skin cancer screening) and operates as the regional coordinator for Poland's National Cancer Network, while investing in a new Nuclear Medicine Center for advanced diagnostic and radiopharmaceutical therapies.

Product overview

Zachodniopomorskie Centrum Onkologii is a regional oncology hospital offering comprehensive cancer diagnosis and treatment services. The facility operates a multi-specialty model with inpatient departments (surgical oncology, clinical radiotherapy, clinical oncology, anesthesiology), diagnostic departments (pathomorphology, diagnostic imaging, laboratory, medical physics), and support services (psycho-oncology, physiotherapy, hospital pharmacy). Outpatient care is delivered through the Hospital-Based Oncology Clinic. The center provides digital health services including electronic registration (e-Rejestracja), telemedicine applications (iWound for post-operative monitoring), and online patient resources (Exercise Atlas). Additional services include cancer prevention programs, clinical trials, and oncological consultations. The facility is constructing a Nuclear Medicine Center (opening January 2027) equipped with Biograph Vision.X and Symbia pro.specta imaging systems.

Differentiator

Problem solved

Functional benefit

Products and services

• Oncological Surgery Department (Oddział Chirurgii Onkologicznej)

Quantifiable outcome

• 80% cure rate for early-stage breast cancer patients at ZCO
• +2 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature5 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• Akademia Czerniaka (Melanoma Academy)coreStrategic or Co-development Partner · 16 June 2026Partner in the national 'Cała Polska sprawdza znamiona' (All of Poland Checks Moles) campaign. Organizes free dermoscopic mole examinations at ZCO during 'Dni Świadomości Czerniaka' awareness days, bringing mobile dermatology clinic 'Fura Zdrowia' to the ZCO parking area.
• Okręgowa Izba Lekarska w Szczecinie (Regional Medical Chamber in Szczecin)coreStrategic or Co-development Partner · 1 October 2024Partner in the 'Rak piersi nie ma barw' (Breast Cancer Has No Colors) social awareness campaign. Co-organized with ZCO to promote breast cancer prevention and screening among women in the Szczecin region. The campaign included photography exhibitions, outdoor advertising, and social media outreach.
• Szczecińska Agencja Artystyczna (Szczecin Artistic Agency)minorGTM or Marketing Partner · 1 October 2024Partner in the 'Rak piersi nie ma barw' breast cancer awareness campaign, contributing artistic production including photography exhibition and campaign materials.
• Pogoń Szczecin (Women's Football Team), King Wilki Morskie (Basketball), SPR Pogoń Szczecin (Handball), Chemik Police (Women's Volleyball), Akademicki Związek Sportowy (Rowing), Szczeciński Klub Kolarski, Klub Motorowy Szczecin, Centrum Żeglarskie, and other sports clubsminorGTM or Marketing Partner · 1 October 2024Sports clubs supporting the 'Rak piersi nie ma barw' breast cancer awareness campaign. Athletes and clubs endorsed the campaign citing personal connections to cancer, helping reach broader audiences through sports community networks.
• Regionalna Fundacja Walki z Rakiem (Regional Foundation for Fighting Cancer)coreStrategic or Co-development PartnerClosely affiliated foundation operating at ZCO, conducting preventive workshops, volunteer activities, fundraising, and patient support. The foundation organizes breast self-examination training in schools and workplaces, runs the 'Profilaktyka, edukacja i promocja zdrowia w ZCO' project funded by Urząd Marszałkowski, and supports patients with wigs, specialized lingerie, and cosmetics for oncology patients. It also conducts fundraising and awareness campaigns.
• Stowarzyszenie Pomocy Chorym na Mięsaki i Czerniaki Sarcoma (Sarcoma and Melanoma Patient Support Association)minorStrategic or Co-development PartnerPartner in the 'Cała Polska sprawdza znamiona' skin cancer screening campaign, collaborating with Akademia Czerniaka and ZCO to raise awareness and provide free dermatological screenings.
• Krajowa Sieć Onkologiczna (National Cancer Network)coreStrategic or Co-development PartnerZCO serves as the regional coordinator for the National Cancer Network (part of the national oncology care coordination program) for the West Pomeranian voivodeship. The hospital operates the Wojewódzki Ośrodek Monitorujący (Provincial Monitoring Center) which oversees implementation of national cancer care standards and provides training for primary care physicians (POZ) through an information hotline.
• Uniwersytet Medyczny w Poznaniu (Medical University of Poznań)minorStrategic or Co-development PartnerProf. Tomasz Banasiewicz from the Medical University of Poznań, co-creator of the iWound application, collaborated with ZCO on the telemedicine pilot project for post-operative wound care. ZCO is described as a teaching hospital with clinical departments.

Scale indicators4 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• European Institute of Oncology (IEO): Leading European cancer center in Milan founded by Umberto Veronesi. Comparable as a comprehensive specialty cancer hospital with multidisciplinary care, advanced radiotherapy, and clinical research, though operating at a far larger scale and with private/foundation funding.
• Charité Comprehensive Cancer Center: Comprehensive cancer center within Charité – Universitätsmedizin Berlin. Comparable as a public university-affiliated oncology program delivering multidisciplinary cancer care, advanced imaging, and research; larger scale and academic focus versus ZCO.
• Gustave Roussy Institute: One of Europe's largest comprehensive cancer centers near Paris. Comparable as a publicly-supported multidisciplinary oncology hospital offering surgery, radiotherapy, systemic therapy, nuclear medicine, and clinical trials at a much larger scale.

Direct peers

• Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie – Państwowy Instytut Badawczy: Poland's national oncology research institute and hospital, operating comprehensive cancer centers in Warsaw and Gliwice. Comparable as a leading Polish public oncology hospital delivering multidisciplinary cancer care, systemic therapy, radiotherapy, and clinical research; ZCO operates at a regional level within the same National Cancer Network.
• Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii: Regional specialty hospital in Wrocław covering oncology, pulmonology, and hematology for Lower Silesia. Comparable as a voivodeship-owned public hospital delivering comprehensive cancer diagnostics and treatment within the National Cancer Network.
• Kujawsko-Pomorskie Centrum Onkologii: Regional oncology hospital in Bydgoszcz serving the Kuyavian-Pomeranian voivodeship. Comparable as a public regional oncology center providing multidisciplinary treatment, screening, and National Cancer Network coordination in a similar Polish regional setting.
• Świętokrzyskie Centrum Onkologii: Regional oncology hospital in Kielce serving the Świętokrzyskie voivodeship. Comparable public oncology center delivering multidisciplinary cancer care, radiotherapy, chemotherapy, and prevention programs under the same NFZ funding model.
• Wielkopolskie Centrum Onkologii: Regional oncology hospital in Poznań serving the Greater Poland voivodeship. Directly comparable as another voivodeship-level public oncology center providing surgery, radiotherapy, systemic therapy, and screening programs under the National Cancer Network framework.

Emerging players

• Affidea Poland: Private operator of outpatient oncology and diagnostic imaging centers across Poland. Comparable as a provider of cancer-related imaging (PET/CT, MRI) and radiotherapy services competing for NFZ and private-pay patients, though operating under a private outpatient model rather than as a public specialty hospital.

Regional players

• Podkarpackie Centrum Onkologii / Wojewódzki Szpital Specjalistyczny im. Fryderyka Chopina: Regional oncology and multispecialty hospital in Rzeszów serving the Subcarpathian voivodeship. Comparable as a voivodeship-level public hospital offering oncology diagnostics and treatment, though ZCO is a cancer-specialized facility while this is a broader specialty hospital.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UC9ENYWHtLFoKn4QTPhrU-Zg
• Facebookfacebook.com/ZachodniopomorskieCentrumOnkologii
• Instagraminstagram.com/onkologia_szczecin
• LinkedInlinkedin.com/company/zachodniopomorskie-centrum-onkologii

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Zachodniopomorskie Centrum Onkologii